Q1 2024

Source filing unavailable

Q1 2024 · —

Revenue

$12.93M

no prior Q1 2023 on file

Net Income

-$12.45M

no prior Q1 2023 on file

EPS Diluted

-$2.07

no prior Q1 2023 on file

Gross Profit$7,201,000—

Operating Income-$9,453,000—

Operating Cash Flow-$12,144,000

Same quarter

no prior Q1 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR